From screening to postpartum follow-up – the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review

BMC Pregnancy and Childbirth

Ib Christian Bygbjerg³  Maximilian de Courten²  Peter Damm¹  Anil Kapur³  Karoline Kragelund Nielsen³ 

[1] Center for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen DK-2100, Denmark;Department of International Health, Immunology and Microbiology, University of Copenhagen, Oester Farimagsgade 5, Building 9, Copenhagen DK-1014, K, Denmark;World Diabetes Foundation, Brogaardsvej 70, Gentofte DK–2820, Denmark

关键词: Screening;    Lifestyle;    Determinants;    Barriers;    Health services;    Gestational diabetes mellitus;   

Others  :  1131679
DOI  :  10.1186/1471-2393-14-41

 received in 2013-06-12, accepted in 2014-01-06,  发布年份 2014

【 摘 要 】

Background

Gestational diabetes mellitus (GDM) – a transitory form of diabetes first recognised during pregnancy complicates between < 1% and 28% of all pregnancies. GDM has important short and long-term health consequences for both the mother and her offspring. To prevent adverse pregnancy outcomes and to prevent or delay future onset of type 2 diabetes in mother and offspring, timely detection, optimum treatment, and preventive postpartum care and follow-up is necessary. However the area remains grossly under-prioritised.

Methods

To investigate determinants and barriers to GDM care from initial screening and diagnosis to prenatal treatment and postpartum follow-up, a PubMed database search to identify quantitative and qualitative studies on the subject was done in September 2012. Fifty-eight relevant studies were reviewed.

Results

Adherence to prevailing GDM screening guidelines and compliance to screening tests seems sub-optimal at best and arbitrary at worst, with no clear or consistent correlation to health care provider, health system or client characteristics. Studies indicate that most women express commitment and motivation for behaviour change to protect the health of their unborn baby, but compliance to recommended treatment and advice is fraught with challenges, and precious little is known about health system or societal factors that hinder compliance and what can be done to improve it. A number of barriers related to health care provider/system and client characteristics have been identified by qualitative studies. Immediately following a GDM pregnancy many women, when properly informed, desire and intend to maintain healthy lifestyles to prevent future diabetes, but find the effort challenging. Adherence to recommended postpartum screening and continued lifestyle modifications seems even lower. Here too, health care provider, health system and client related determinants and barriers were identified. Studies reveal that sense of self-efficacy and social support are key determinants.

Conclusions

The paper identifies and discusses determinants and barriers for GDM care, fully recognising that these are highly dependent on the context.

【 授权许可】

   
2014 Nielsen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG: Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 2012, 25(6):600-610.
• [2]Aljohani N, Rempel BM, Ludwig S, Morris M, McQuillen K, Cheang M, et al.: Gestational diabetes in Manitoba during a twenty-year period. Clin Invest Med 2008, 31(3):E131-E137.
• [3]Anna V, van der Ploeg HP, Cheung NW, Huxley RR, Bauman AE: Sociodemographic correlates of the increasing trend in prevalence of gestational diabetes mellitus in a large population of women between 1995 and 2005. Diabetes Care 2008, 31(12):2288-2293.
• [4]Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM: An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol 2004, 103(3):526-533.
• [5]American Diabetes Association: Diagnosis and classification of diabetes mellitus 2013. Diabetes Care 2013, 36(Suppl 1):S67-S74.
• [6]Black MH, Sacks DA, Xiang AH, Lawrence JM: Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care 2010, 33(12):2524-2530.
• [7]Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al.: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358(19):1991-2002.
• [8]Damm P: Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet 2009, 104(Suppl 1):S25-S26.
• [9]Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25(10):1862-1868.
• [10]Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005, 352(24):2477-2486.
• [11]Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al.: A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009, 361(14):1339-1348.
• [12]Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, et al.: Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002, 51(9):2796-2803.
• [13]Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al.: Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008, 93(12):4774-4779.
• [14]Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, et al.: Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 2006, 55(2):517-522.
• [15]Nielsen KK, De Courten M, Kapur A: The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus - lessons from projects funded by the World Diabetes Foundation. Glob Health Action 2012, 5:17277.
• [16]Landon MB, Gabbe SG, Sachs L: Management of diabetes mellitus and pregnancy: a survey of obstetricians and maternal-fetal specialists. Obstet Gynecol 1990, 75(4):635-640.
• [17]Marrero DG, Moore P, Langefeld CD, Golichowski A, Clark CM Jr: Care of diabetic pregnant women by primary-care physicians. Reported strategies for managing pregestational and gestational diabetes. Diabetes Care 1992, 15(1):101-107.
• [18]Sievenpiper JL, McDonald SD, Grey V, Don-Wauchope AC: Missed follow-up opportunities using a two-step screening approach for gestational diabetes. Diabetes Res Clin Pract 2012, 96(2):e43-e46.
• [19]Gazmararian JA, Cogswell ME, Koplan JP: The relationship between characteristics of obstetrician-gynecologists and rates of recommended prenatal care screening tests. HMO Pract 1996, 10(3):108-113.
• [20]Ruengkhachorn I, Sunsaneevithayakul P, Boriboonhirunsarn D: Non-compliance to clinical practice guideline for screening of gestational diabetes mellitus in Siriraj Hospital. J Med Assoc Thai 2006, 89(6):767-772.
• [21]Moses RG, Webb AJ, Comber CD, Walton JG, Coleman KJ, Davis WS, et al.: Gestational diabetes mellitus: compliance with testing. Aust N Z J Obstet Gynaecol 2003, 43(6):469-470.
• [22]Yapa M, Simmons D: Screening for gestational diabetes mellitus in a multiethnic population in New Zealand. Diabetes Res Clin Pract 2000, 48(3):217-223.
• [23]Blatt AJ, Nakamoto JM, Kaufman HW: Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol 2011, 117(1):61-68.
• [24]Cullinan J, Gillespie P, Owens L, Dunne F: Accessibility and screening uptake rates for gestational diabetes mellitus in Ireland. Health Place 2012, 18(2):339-348.
• [25]Cullinan J, Gillespie P, Owens L, Dunne FP: The impact of travel distance on the decision to attend for screening for gestational diabetes mellitus. Ir Med J 2012, 105(5 Suppl):18-20.
• [26]Pedula KL, Hillier TA, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ: Ethnic differences in gestational oral glucose screening in a large US population. Ethn Dis 2009, 19(4):414-419.
• [27]American College of Obstetricians and Gynecologists: ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001, 98(3):525-538.
• [28]Ruggiero L, Spirito A, Bond A, Coustan D, McGarvey S: Impact of social support and stress on compliance in women with gestational diabetes. Diabetes Care 1990, 13(4):441-443.
• [29]Bandyopadhyay M, Small R, Davey MA, Oats JJ, Forster DA, Aylward A: Lived experience of gestational diabetes mellitus among immigrant South Asian women in Australia. Aust N Z J Obstet Gynaecol 2011, 51(4):360-364.
• [30]Doran F, Davis K: Gestational diabetes mellitus in Tonga: insights from healthcare professionals and women who experienced gestational diabetes mellitus. N Z Med J 2010, 123(1326):59-67.
• [31]Evans MK, O’Brien B: Gestational diabetes: the meaning of an at-risk pregnancy. Qual Health Res 2005, 15(1):66-81.
• [32]Lawson EJ, Rajaram S: A transformed pregnancy: the psychosocial consequences of gestational diabetes. Sociol Health Illn 1994, 16(4):536-562.
• [33]Neufeld HT: Food perceptions and concerns of aboriginal women coping with gestational diabetes in Winnipeg, Manitoba. J Nutr Educ Behav 2011, 43(6):482-491.
• [34]Persson M, Winkvist A, Mogren I: ‘From stun to gradual balance’–women’s experiences of living with gestational diabetes mellitus. Scand J Caring Sci 2010, 24(3):454-462.
• [35]Persily CA: Relationships between the perceived impact of gestational diabetes mellitus and treatment adherence. J Obstet Gynecol Neonatal Nurs 1996, 25(7):601-607.
• [36]Hjelm K, Bard K, Nyberg P, Apelqvist J: Management of gestational diabetes from the patient’s perspective–a comparison of Swedish and Middle-Eastern born women. J Clin Nurs 2007, 16(1):168-178.
• [37]Hjelm K, Berntorp K, Frid A, Aberg A, Apelqvist J: Beliefs about health and illness in women managed for gestational diabetes in two organisations. Midwifery 2008, 24(2):168-182.
• [38]Hirst JE, Tran TS, Do MA, Rowena F, Morris JM, Jeffery HE: Women with gestational diabetes in Vietnam: a qualitative study to determine attitudes and health behaviours. BMC Pregnancy Childbirth 2012, 12:81.
• [39]Collier SA, Mulholland C, Williams J, Mersereau P, Turay K, Prue C: A qualitative study of perceived barriers to management of diabetes among women with a history of diabetes during pregnancy. J Womens Health (Larchmt ) 2011, 20(9):1333-1339.
• [40]Mersereau P, Williams J, Collier SA, Mulholland C, Turay K, Prue C: Barriers to managing diabetes during pregnancy: the perceptions of health care practitioners. Birth 2011, 38(2):142-149.
• [41]Almario CV, Ecker T, Moroz LA, Bucovetsky L, Berghella V, Baxter JK: Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am J Obstet Gynecol 2008, 198(5):528-5.
• [42]Kim C, Tabaei BP, Burke R, McEwen LN, Lash RW, Johnson SL, et al.: Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006, 96(9):1643-1648.
• [43]Lawrence JM, Black MH, Hsu JW, Chen W, Sacks DA: Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 2010, 33(3):569-576.
• [44]Morrison MK, Collins CE, Lowe JM: Postnatal testing for diabetes in Australian women following gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2009, 49(5):494-498.
• [45]Smirnakis KV, Chasan-Taber L, Wolf M, Markenson G, Ecker JL, Thadhani R: Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 2005, 106(6):1297-1303.
• [46]Dietz PM, Vesco KK, Callaghan WM, Bachman DJ, Bruce FC, Berg CJ, et al.: Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy. Obstet Gynecol 2008, 112(4):868-874.
• [47]Beischer NA, Wein P, Sheedy MT: A follow-up program for women with previous gestational diabetes mellitus. Med J Aust 1997, 166(7):353-357.
• [48]Baker AM, Brody SC, Salisbury K, Schectman R, Hartmann KE: Postpartum glucose tolerance screening in women with gestational diabetes in the state of North Carolina. N C Med J 2009, 70(1):14-19.
• [49]Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J: Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004, 103(6):1229-1234.
• [50]Keely E, Clark H, Karovitch A, Graham I: Screening for type 2 diabetes following gestational diabetes: family physician and patient perspectives. Can Fam Physician 2010, 56(6):558-563.
• [51]Shah BR, Lipscombe LL, Feig DS, Lowe JM: Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study. BJOG 2011, 118(12):1484-1490.
• [52]Stuebe A, Ecker J, Bates DW, Zera C, Bentley-Lewis R, Seely E: Barriers to follow-up for women with a history of gestational diabetes. Am J Perinatol 2010, 27(9):705-710.
• [53]Kaufmann RC, Smith T, Bochantin T, Khardori R, Evans MS, Steahly L: Failure to obtain follow-up testing for gestational diabetic patients in a rural population. Obstet Gynecol 1999, 93(5 Pt 1):734-737.
• [54]Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW: Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006, 108(6):1456-1462.
• [55]Clark HD, Graham ID, Karovitch A, Keely EJ: Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 2009, 200(6):634-637.
• [56]Shea AK, Shah BR, Clark HD, Malcolm J, Walker M, Karovitch A, et al.: The effectiveness of implementing a reminder system into routine clinical practice: does it increase postpartum screening in women with gestational diabetes? Chronic Dis Can 2011, 31(2):58-64.
• [57]Kim C, McEwen LN, Kerr EA, Piette JD, Chames MC, Ferrara A, et al.: Preventive counseling among women with histories of gestational diabetes mellitus. Diabetes Care 2007, 30(10):2489-2495.
• [58]Ferrara A, Peng T, Kim C: Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2009, 32(2):269-274.
• [59]Hunt KJ, Conway DL: Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 2008, 198(4):404-406.
• [60]Kwong S, Mitchell RS, Senior PA, Chik CL: Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care 2009, 32(12):2242-2244.
• [61]Bennett WL, Ennen CS, Carrese JA, Hill-Briggs F, Levine DM, Nicholson WK, et al.: Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study. J Womens Health (Larchmt ) 2011, 20(2):239-245.
• [62]Hoedjes M, Berks D, Vogel I, Franx A, Duvekot JJ, Oenema A, et al.: Motivators and barriers to a healthy postpartum lifestyle in women at increased cardiovascular and metabolic risk: a focus-group study. Hypertens Pregnancy 2012, 31(1):147-155.
• [63]Zehle K, Smith BJ, Chey T, McLean M, Bauman AE, Cheung NW: Psychosocial factors related to diet among women with recent gestational diabetes: opportunities for intervention. Diabetes Educ 2008, 34(5):807-814.
• [64]Smith BJ, Cheung NW, Bauman AE, Zehle K, McLean M: Postpartum physical activity and related psychosocial factors among women with recent gestational diabetes mellitus. Diabetes Care 2005, 28(11):2650-2654.
• [65]Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA: Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007, 30(9):2281-2286.
• [66]Stage E, Ronneby H, Damm P: Lifestyle change after gestational diabetes. Diabetes Res Clin Pract 2004, 63(1):67-72.
• [67]Kim C, McEwen LN, Kieffer EC, Herman WH, Piette JD: Self-efficacy, social support, and associations with physical activity and body mass index among women with histories of gestational diabetes mellitus. Diabetes Educ 2008, 34(4):719-728.
• [68]Koh D, Miller YD, Marshall AL, Brown WJ, McIntyre D: Health-enhancing physical activity behaviour and related factors in postpartum women with recent gestational diabetes mellitus. J Sci Med Sport 2010, 13(1):42-45.
• [69]Swan W, Kilmartin G, Liaw ST: Assessment of readiness to prevent type 2 diabetes in a population of rural women with a history of gestational diabetes. Rural Remote Health 2007, 7(4):802.
• [70]Graco M, Garrard J, Jasper AE: Participation in physical activity: perceptions of women with a previous history of gestational diabetes mellitus. Health Promot J Austr 2009, 20(1):20-25.
• [71]Nicklas JM, Zera CA, Seely EW, Abdul-Rahim ZS, Rudloff ND, Levkoff SE: Identifying postpartum intervention approaches to prevent type 2 diabetes in women with a history of gestational diabetes. BMC Pregnancy Childbirth 2011, 11:23.
• [72]Razee H, van der Ploeg HP, Blignault I, Smith BJ, Bauman AE, McLean M, et al.: Beliefs, barriers, social support, and environmental influences related to diabetes risk behaviours among women with a history of gestational diabetes. Health Promot J Austr 2010, 21(2):130-137.
• [73]Symons DD, Ulbrecht JS: Understanding exercise beliefs and behaviors in women with gestational diabetes mellitus. Diabetes Care 2006, 29(2):236-240.
• [74]McNamee P, Ternent L, Hussein J: Barriers in accessing maternal healthcare: evidence from low-and middle-income countries. Expert Rev Pharmacoecon Outcomes Res 2009, 9(1):41-48.
• [75]Simkhada B, Teijlingen ER, Porter M, Simkhada P: Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs 2008, 61(3):244-260.
• [76]Kapur A: Pregnancy: a window of opportunity for improving current and future health. Int J Gynaecol Obstet 2011, 115(Suppl 1):S50-S51.
• [77]Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, et al.: Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011, 54(2):300-307.
• [78]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6):393-403.
• [79]Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344(18):1343-1350.
• [80]Ratner RE: Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care 2007, 30(Suppl 2):S242-S245.
• [81]Hu G, Tian H, Zhang F, Liu H, Zhang C, Zhang S, et al.: Tianjin Gestational Diabetes Mellitus Prevention Program: study design, methods, and 1-year interim report on the feasibility of lifestyle intervention program. Diabetes Res Clin Pract 2012, 98(3):508-517.
• [82]Infanti JJ, Dunne FP, Dea O, Gillespie P, Gibson I, Glynn LG, et al.: An evaluation of Croi MyAction community lifestyle modification programme compared to standard care to reduce progression to diabetes/pre-diabetes in women with prior gestational diabetes mellitus (GDM): study protocol for a randomised controlled trial. Trials 2013, 14(1):121.
• [83]Shih ST, Davis-Lameloise N, Janus ED, Wildey C, Versace VL, Hagger V, et al.: Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trial. Trials 2013, 14(1):339.
• [84]Khambalia AZ, Ford JB, Nassar N, Shand AW, McElduff A, Roberts CL: Occurrence and recurrence of diabetes in pregnancy. Diabet Med 2013, 30(4):452-456.
• [85]Seshiah V, Balaji V, Balaji MS, Paneerselvam A, Arthi T, Thamizharasi M, et al.: Prevalence of gestational diabetes mellitus in South India (Tamil Nadu)–a community based study. J Assoc Physicians India 2008, 56:329-333.
• [86]Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL, et al.: Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china. Diabetes Care 2013, 36(3):586-590.
• [87]International Diabetes Federation: Diabetes Atlas. 5th edition. Brussels: International Diabetes Federation; 2011.
• [88]World Health Organization: Maternal mortality. Fact sheet No. 348. 2010. http://www.who.int/mediacentre/factsheets/fs348/en/ webcite accessed 30 May 2013